---
authors:
- Barry, Henry C
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/40106300/
file_path: 2025/03/in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists.md
issue: '3'
keywords:
- Diabetes
last_updated: '2025-07-30'
original_format: PubMed
pages: '281'
patient_population: Geriatric
peer_reviewed: true
pmid: '40106300'
processed_date: '2025-07-30'
publication_date: '2025-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
  Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '40106300'
  title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  authors:
  - last_name: Barry
    fore_name: Henry C
    initials: HC
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '3'
  publication_info:
    year: '2025'
    month: '03'
    full_date: '2025-03-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '40106300'
  title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  authors:
  - name: Barry HC
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 Mar
- pmid: '38663919'
  title: 'Effect of combination treatment with glucagon-like peptide-1 receptor agonists
    and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and
    serious renal events: population based cohort study.'
  authors:
  - name: Simms-Williams N
    authtype: Author
    clusterid: ''
  - name: Treves N
    authtype: Author
    clusterid: ''
  - name: Yin H
    authtype: Author
    clusterid: ''
  - name: Lu S
    authtype: Author
    clusterid: ''
  - name: Yu O
    authtype: Author
    clusterid: ''
  - name: Pradhan R
    authtype: Author
    clusterid: ''
  - name: Renoux C
    authtype: Author
    clusterid: ''
  - name: Suissa S
    authtype: Author
    clusterid: ''
  - name: Azoulay L
    authtype: Author
    clusterid: ''
  source: BMJ
  pubdate: 2024 Apr 25
- pmid: '33975892'
  title: 'SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes:
    a clinical practice guideline.'
  authors:
  - name: Li S
    authtype: Author
    clusterid: ''
  - name: Vandvik PO
    authtype: Author
    clusterid: ''
  - name: Lytvyn L
    authtype: Author
    clusterid: ''
  - name: Guyatt GH
    authtype: Author
    clusterid: ''
  - name: Palmer SC
    authtype: Author
    clusterid: ''
  - name: Rodriguez-Gutierrez R
    authtype: Author
    clusterid: ''
  - name: Foroutan F
    authtype: Author
    clusterid: ''
  - name: Agoritsas T
    authtype: Author
    clusterid: ''
  - name: Siemieniuk RAC
    authtype: Author
    clusterid: ''
  - name: Walsh M
    authtype: Author
    clusterid: ''
  - name: Frere L
    authtype: Author
    clusterid: ''
  - name: Tunnicliffe DJ
    authtype: Author
    clusterid: ''
  - name: Nagler EV
    authtype: Author
    clusterid: ''
  - name: Manja V
    authtype: Author
    clusterid: ''
  - name: Åsvold BO
    authtype: Author
    clusterid: ''
  - name: Jha V
    authtype: Author
    clusterid: ''
  - name: Vermandere M
    authtype: Author
    clusterid: ''
  - name: Gariani K
    authtype: Author
    clusterid: ''
  - name: Zhao Q
    authtype: Author
    clusterid: ''
  - name: Ren Y
    authtype: Author
    clusterid: ''
  - name: Cartwright EJ
    authtype: Author
    clusterid: ''
  - name: Gee P
    authtype: Author
    clusterid: ''
  - name: Wickes A
    authtype: Author
    clusterid: ''
  - name: Ferns L
    authtype: Author
    clusterid: ''
  - name: Wright R
    authtype: Author
    clusterid: ''
  - name: Li L
    authtype: Author
    clusterid: ''
  - name: Hao Q
    authtype: Author
    clusterid: ''
  - name: Mustafa RA
    authtype: Author
    clusterid: ''
  source: BMJ
  pubdate: 2021 May 11
- pmid: '33441402'
  title: 'Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like
    peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and
    network meta-analysis of randomised controlled trials.'
  authors:
  - name: Palmer SC
    authtype: Author
    clusterid: ''
  - name: Tendal B
    authtype: Author
    clusterid: ''
  - name: Mustafa RA
    authtype: Author
    clusterid: ''
  - name: Vandvik PO
    authtype: Author
    clusterid: ''
  - name: Li S
    authtype: Author
    clusterid: ''
  - name: Hao Q
    authtype: Author
    clusterid: ''
  - name: Tunnicliffe D
    authtype: Author
    clusterid: ''
  - name: Ruospo M
    authtype: Author
    clusterid: ''
  - name: Natale P
    authtype: Author
    clusterid: ''
  - name: Saglimbene V
    authtype: Author
    clusterid: ''
  - name: Nicolucci A
    authtype: Author
    clusterid: ''
  - name: Johnson DW
    authtype: Author
    clusterid: ''
  - name: Tonelli M
    authtype: Author
    clusterid: ''
  - name: Rossi MC
    authtype: Author
    clusterid: ''
  - name: Badve SV
    authtype: Author
    clusterid: ''
  - name: Cho Y
    authtype: Author
    clusterid: ''
  - name: Nadeau-Fredette AC
    authtype: Author
    clusterid: ''
  - name: Burke M
    authtype: Author
    clusterid: ''
  - name: Faruque LI
    authtype: Author
    clusterid: ''
  - name: Lloyd A
    authtype: Author
    clusterid: ''
  - name: Ahmad N
    authtype: Author
    clusterid: ''
  - name: Liu Y
    authtype: Author
    clusterid: ''
  - name: Tiv S
    authtype: Author
    clusterid: ''
  - name: Millard T
    authtype: Author
    clusterid: ''
  - name: Gagliardi L
    authtype: Author
    clusterid: ''
  - name: Kolanu N
    authtype: Author
    clusterid: ''
  - name: Barmanray RD
    authtype: Author
    clusterid: ''
  - name: McMorrow R
    authtype: Author
    clusterid: ''
  - name: Raygoza Cortez AK
    authtype: Author
    clusterid: ''
  - name: White H
    authtype: Author
    clusterid: ''
  - name: Chen X
    authtype: Author
    clusterid: ''
  - name: Zhou X
    authtype: Author
    clusterid: ''
  - name: Liu J
    authtype: Author
    clusterid: ''
  - name: Rodríguez AF
    authtype: Author
    clusterid: ''
  - name: González-Colmenero AD
    authtype: Author
    clusterid: ''
  - name: Wang Y
    authtype: Author
    clusterid: ''
  - name: Li L
    authtype: Author
    clusterid: ''
  - name: Sutanto S
    authtype: Author
    clusterid: ''
  - name: Solis RC
    authtype: Author
    clusterid: ''
  - name: Díaz González-Colmenero F
    authtype: Author
    clusterid: ''
  - name: Rodriguez-Gutierrez R
    authtype: Author
    clusterid: ''
  - name: Walsh M
    authtype: Author
    clusterid: ''
  - name: Guyatt G
    authtype: Author
    clusterid: ''
  - name: Strippoli GFM
    authtype: Author
    clusterid: ''
  source: BMJ
  pubdate: 2021 Jan 13
- pmid: '33583813'
  title: An updated perspective and pooled analysis of cardiovascular outcome trials
    of GLP-1 receptor agonists and SGLT-2 inhibitors.
  authors:
  - name: Kılıçkap M
    authtype: Author
    clusterid: ''
  - name: Kayıkçıoğlu M
    authtype: Author
    clusterid: ''
  - name: Tokgözoğlu L
    authtype: Author
    clusterid: ''
  source: Anatol J Cardiol
  pubdate: 2021 Feb
---

# In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.

**Authors:** Barry, Henry C

**Published in:** American family physician | Vol. 111, No. 3 | 2025-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/40106300/)

## Clinical Information

**Population:** Geriatric | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/40106300/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
